Dr VK Paul

Requirement, Timing Of Covid Vaccine Booster Will Be Based On Scientific Decisions: Says Govt

The requirement, timing and nature of Covid vaccine booster shots will be based on scientific decisions said Dr VK Paul, Member-Health, Niti Aayog on Wednesday. Speaking to ANI, Dr Paul…

View Post

Looking Into Booster Dose Issue: Govt

Dr V K Paul, NITI Aayog member (health) said on Tuesday announced that national expert committee on Covid-19 vaccination has discussed the issue of giving booster vaccine dose and it…

View Post

Delta Plus Variant Is Not Yet Classified As Variant Of Concern: Dr. Paul

In the context of the public discourse regarding detection of new variants, Member (Health), NITI Aayog, Dr. VK Paul has reminded the public that the newly detected Delta Plus Variant…

View Post

No Significant Shift In Age Distribution Of COVID-19 Case: NITI Aayog Member

Dr. VK Paul, Member (Health) of the NITI Aayog, on Monday said that there is no significant shift in the age distribution of COVID-19 cases in the second wave as…

View Post

India Has Sent COVID Vaccines To 24 Countries So Far Says Dr VK Paul, NITI Aayog Member

Dr VK Paul on Tuesday informed that India Has Sent COVID Vaccines To 24 Countries So Far. Speaking at a press conference, Dr Paul noted that India can draw huge…

View Post

Spotlight

Is Vaccine Hesitancy Reason Behind Low Turnout For Covid-19 Vaccine In India? How Can It Be Overcome?

Covid-19 vaccine doses are being given to around 50 people in India per session, half of the government’s projected average. This is primarily because of the hesitation in the vaccine, which…

View Post

Covishield, Covaxin Are Safest Of COVID-19 Vaccines, Side-Effects Are Negligible: VK Paul

Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health),…

View Post

Menu

Dr VK Paul

Requirement, Timing Of Covid Vaccine Booster Will Be Based On Scientific Decisions: Says Govt

Looking Into Booster Dose Issue: Govt

Delta Plus Variant Is Not Yet Classified As Variant Of Concern: Dr. Paul

No Significant Shift In Age Distribution Of COVID-19 Case: NITI Aayog Member

India Has Sent COVID Vaccines To 24 Countries So Far Says Dr VK Paul, NITI Aayog Member

Is Vaccine Hesitancy Reason Behind Low Turnout For Covid-19 Vaccine In India? How Can It Be Overcome?

Covishield, Covaxin Are Safest Of COVID-19 Vaccines, Side-Effects Are Negligible: VK Paul

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial

FDA Moves to Restrict Psychoactive Mushrooms Used in Edibles Amid Growing Concerns

Revolutionary CAR-T Cell Therapy Developed by AIIMS Researchers Offers New Hope for Multiple Myeloma Patients

Severe Strain of Bird Flu Spreading Rapidly: Is India at Risk of Another Pandemic?

India Achieves Significant Progress in Reducing Malaria Cases: WHO Report